Efficient and beta-Stereoselective Synthesis of 4(5)-(beta-D-Ribofuranosyl)- and 4(5)-(2-Deoxyribofuranosyl)imidazoles(1). 1996

Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
Osaka University of Pharmaceutical Sciences, 4-20-1 Nasahara, Takatsuki, Osaka 569-11, Japan.

A synthetic route to 4(5)-(beta-D-ribofuranosyl)imidazole (1), starting from 2,3,5-tri-O-benzyl-D-ribose (5), was developed via a Mitsunobu cyclization. Reaction of 5 with the lithium salt of bis-protected imidazole afforded the corresponding 5-ribosylimidazole 7RS. Hydrolysis of 7RS gave a 1:1 mixture of diol isomers 8R and 8S having an unsubstituted imidazole. Mitsunobu cyclization of the mixture 8RS using N,N,N',N'-tetramethylazodicarboxamide and Bu(3)P exclusively afforded benzylated beta-ribofuranosyl imidazole 9beta in 92% yield, accompanied by alpha-anomer 9alpha, in a ratio of 26.3:1. The configuration of 9beta was established by X-ray crystallography of ethoxycarbonyl derivative 10beta. Reductive debenzylation of 9beta over Pd/C was carried out, and the synthesis of 1 was attained from starting 5 in four steps and 87% overall yield. This synthetic methodology was extended to the synthesis of 4(5)-(2-deoxy-beta-D-ribofuranosyl)imidazole (2). Mitsunobu cyclization of a 1:1 mixture of the corresponding diol isomers 14RS produced 15beta and 15alpha in a ratio of 5.4:1. The synthesis of 2 was attained in a 59% overall yield from the starting 3,5-di-O-benzyl-2-deoxy-D-ribose (12). beta-Stereoselective glycosylation in the key step is discussed and explained by intramolecular hydrogen bonding between an NH in the imidazole and the oxygen functional group in the sugar moiety.

UI MeSH Term Description Entries

Related Publications

Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
June 1989, Nucleic acids research,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
July 1969, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
December 1990, Nucleic acids research,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
August 1976, The Journal of organic chemistry,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
January 1975, Journal of the Chemical Society. Perkin transactions 1,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
August 1976, Journal of medicinal chemistry,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
January 1981, Journal of medicinal chemistry,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
January 1975, Zeitschrift fur Naturforschung. Section C, Biosciences,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
May 1980, Journal of pharmaceutical sciences,
Shinya Harusawa, and Yoshihiko Murai, and Hideki Moriyama, and Tomonari Imazu, and Hirofumi Ohishi, and Ryuji Yoneda, and Takushi Kurihara
December 1975, Journal of medicinal chemistry,
Copied contents to your clipboard!